SPL 2.00% 9.8¢ starpharma holdings limited

Covid - Vaccine - Viraleze, page-229

  1. 15,657 Posts.
    lightbulb Created with Sketch. 5718
    Stop blaming everyone else .... all this big pharma nonsense about Viraleze delays is nothing but conjecture from you. You also posted a response from the TGA in Post #:74837243 dated 20 July stating a decision on Viraleze is likely in 4-8 weeks, which has come and gone with no update from Starpharma or the TGA ... I am guessing Pfizer or the like will get the blame for this not happening soon enough ? lol


    Perhaps the TGA submission for Viraleze compiled by Starpharma was deficient in some areas, which has caused the delay - we know for a fact that there was no trial data supplied in the original submission because the company in its wisdom chose not to do one back then ?


    .... and take the TGA out of the equation and look at the ROW - where are all the other regulatory approvals for Viraleze given the company constantly touted they were continuing Viraleze submissions in other regions ? The last official Viraleze approval was over 12 months ago in Malaysia so the common denominator may just be deficiencies in the regulatory submissions given we haven't seen one since then ?


    upload_2024-8-26_9-41-59.png
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.